Danger of sudden vision loss: the new FDA warning about GLP-1 weight loss injections
FDA orders new warnings for GLP-1 weight-loss and diabetes drugs over a rare optic nerve condition that can cause permanent vision loss; regulators say the absolute risk is very low and advise patients not to stop treatment without medical guidance
We haven't written up this one. Ynetnews Culture has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
